Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Ruff

Showing results (41-50 of 223) with videos related to

Pageof 23
Sort By:
Chest|June 9, 2019
ResponseGregory Y H Lip, Christian T Ruff, Lisa Moores, et al.
Chest|June 9, 2019
ResponseGregory Y H Lip, Christian T Ruff, Lisa Moores, et al.
Nature Medicine|March 9, 2022
Tirzepatide for diabetes: on track to SURPASS current therapyFilipe A Moura, Benjamin M Scirica, Christian T Ruff
Circulation|May 19, 2025
Factor XI Inhibition for Atrial Fibrillation: Where Do We Stand?Siddharth M Patel, Robert P Giugliano, Christian T Ruff
Chest|June 9, 2019
ResponseGregory Y H Lip, Christian T Ruff, Lisa Moores, et al.
Circulation|July 21, 2016
Management of Bleeding With Non-Vitamin K Antagonist Oral Anticoagulants in the Era of Specific Reversal AgentsChristian T Ruff, Robert P Giugliano, Elliott M Antman
Circulation|October 26, 2020
Response by Marston et al to Letter Regarding Article, "The Effect of PCSK9 (Proprotein Convertase Subtilisin/Kexin Type 9) Inhibition on the Risk of Venous Thromboembolism"Nicholas A Marston, Christian T Ruff, Marc S Sabatine
Plos One|March 18, 2021
Evaluating the effects of socioeconomic status on stroke and bleeding risk scores and clinical events in patients on oral anticoagulant for new onset atrial fibrillationKourosh Ravvaz, John A Weissert, Arshad Jahangir, et al.
Southern Medical Journal|December 1, 1988
RhinoscleromaA Lenis, T Ruff, J A Diaz, et al.
Lancet (London, England)|July 8, 2014
New oral anticoagulants in patients with atrial fibrillation - Authors'replyChristian T Ruff, Robert P Giugliano, Eugene Braunwald, et al.
Pageof 23

Showing results (41-50 of 223) with videos related to

Sort By:
Pageof 23
Chest|June 9, 2019
ResponseGregory Y H Lip, Christian T Ruff, Lisa Moores, et al.
Chest|June 9, 2019
ResponseGregory Y H Lip, Christian T Ruff, Lisa Moores, et al.
Nature Medicine|March 9, 2022
Tirzepatide for diabetes: on track to SURPASS current therapyFilipe A Moura, Benjamin M Scirica, Christian T Ruff
Circulation|May 19, 2025
Factor XI Inhibition for Atrial Fibrillation: Where Do We Stand?Siddharth M Patel, Robert P Giugliano, Christian T Ruff
Chest|June 9, 2019
ResponseGregory Y H Lip, Christian T Ruff, Lisa Moores, et al.
Circulation|July 21, 2016
Management of Bleeding With Non-Vitamin K Antagonist Oral Anticoagulants in the Era of Specific Reversal AgentsChristian T Ruff, Robert P Giugliano, Elliott M Antman
Circulation|October 26, 2020
Response by Marston et al to Letter Regarding Article, "The Effect of PCSK9 (Proprotein Convertase Subtilisin/Kexin Type 9) Inhibition on the Risk of Venous Thromboembolism"Nicholas A Marston, Christian T Ruff, Marc S Sabatine
Plos One|March 18, 2021
Evaluating the effects of socioeconomic status on stroke and bleeding risk scores and clinical events in patients on oral anticoagulant for new onset atrial fibrillationKourosh Ravvaz, John A Weissert, Arshad Jahangir, et al.
Southern Medical Journal|December 1, 1988
RhinoscleromaA Lenis, T Ruff, J A Diaz, et al.
Lancet (London, England)|July 8, 2014
New oral anticoagulants in patients with atrial fibrillation - Authors'replyChristian T Ruff, Robert P Giugliano, Eugene Braunwald, et al.
Pageof 23